Trial funded in part by a National Institute on Aging Small Business Innovation Research (SBIR) Grant

Read more:
Longeveron Announces Successful Completion of Phase 2b Clinical Study of Lomecel-B Infusion to Treat Aging Frailty

Related Post

Leave a comment

Your email address will not be published. Required fields are marked *


Refresh